Literature DB >> 10362912

Issues relating to the assessment of migraine recurrence following triptan therapy.

D Millson, S Tepper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10362912     DOI： 10.1046/j.1468-1331.1999.6405251.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  3 in total

1.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Headache Recurrence and Treatment.

Authors:  Sheena K. Aurora; John Dempsey
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

Review 3.  WITHDRAWN: Rizatriptan for acute migraine.

Authors:  A D Oldman; L A Smith; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.